Access cutting-edge mild or moderate asthma with allergic sensitization treatment through this phase 2 clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Indianapolis location
Preparing your pre-screening questions…
Access mild or moderate asthma with allergic sensitization specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mild or moderate asthma with allergic sensitization treatment provided free
Check if you qualify for this mild or moderate asthma with allergic sensitization clinical trial in Indianapolis, IN
No-Cost Study Care
Local to Indianapolis
Convenient for IN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to learn more about if taking a supplement called 5-hydroxytryptophan (5HTP) can improve breathing and anxiety symptoms related to asthma. To help learn more subjects will either be assigned to a group that is taking the supplement (5HTP) or a group that is taking a placebo. This will be decided randomly. Later in the study subjects will crossover to the other group.There are 5 study visits over the course of about 12 weeks.
Sponsor: Indiana University
Yes, this clinical trial (NCT04160910) has an active research site in Indianapolis, IN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for mild or moderate asthma with allergic sensitization treatment options in Indianapolis, IN, this clinical trial (NCT04160910) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced mild or moderate asthma with allergic sensitization specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all mild or moderate asthma with allergic sensitization clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Indianapolis — not just this study.
Browse Leukemia Trials in Indianapolis →